Excelsior Medical Co., Ltd. (TPE: 4104)
Taiwan
· Delayed Price · Currency is TWD
85.90
-0.20 (-0.23%)
Jan 20, 2025, 1:30 PM CST
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.06B TWD in the quarter ending September 30, 2024, with 1.95% growth. This brings the company's revenue in the last twelve months to 8.45B, up 5.41% year-over-year. In the year 2023, Excelsior Medical had annual revenue of 8.23B with 14.56% growth.
Revenue (ttm)
8.45B
Revenue Growth
+5.41%
P/S Ratio
1.66
Revenue / Employee
61.20M
Employees
138
Market Cap
14.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
Dec 31, 2019 | 6.46B | 112.33M | 1.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |